ClinicalTrials.Veeva

Menu

Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate

K

Klinikum Ludwigshafen

Status

Completed

Conditions

Amyotrophic Lateral Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT01955369
837.253.09

Details and patient eligibility

About

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria
  • minimum of 18 years
  • minimum of 6 months of residency in Rhinelnad-Palatinate

Exclusion criteria

  • patients below 18 years
  • ALS patients outside Rhineland-Palatinate

Trial design

200 participants in 1 patient group

Amyotrophic lateral sclerosis patients
Description:
Patients were included into the registry if they had a new diagnosis of ALS, a minimum age of 18 years and lived in Rhineland-Palatinate for at least 6 months before date of diagnosis. Diagnosis was based upon the revised El Escorial criteria.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems